aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Manassas, Virginia, Notal Vision is a digital health company dedicated to extending eye disease management from the clinic to the home. Their core mission is to improve vision outcomes by addressing unmet diagnostic needs in ophthalmology through home-based, patient-operated diagnostics and AI-enabled data analysis. Notal Vision offers innovative solutions for age-related macular degeneration (AMD) management, allowing for more precise and timely interventions.
Notal Vision has garnered attention for its pioneering approach and has been supported by notable investors and industry experts. The company’s key achievements include the successful implementation of home diagnostic services that have significantly impacted patient care and outcomes. By integrating advanced technology with patient-centric care, Notal Vision has made a substantial impact on the field of ophthalmology, setting new standards for remote eye disease management.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Diagnostic Services
Technology
Analytics, AI
Tags
Healthtech, TeleMedicine
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Consumers, Enterprise
Geographic Exposure
Americas
When was Notal Vision founded?
Notal Vision was founded in 2000.
Where is Notal Vision’s headquarters located?
Notal Vision’s headquarters is located in Manassas, US.
When was Notal Vision’s last funding round?
Notal Vision’s most recent funding round was for $60M (USD) in June 2021.
How many employees does Notal Vision have?
Notal Vision has 100 employees as of Feb 4, 2024.
How much has Notal Vision raised to-date?
As of July 05, 2023, Notal Vision has raised a total of $85M (USD) since Jun 1, 2021.
Add Comparison
Total Raised to Date
$85M
USD
Last Update Jun 1, 2021
Last Deal Details
$60M
USD
Jun 1, 2021
Series D
Total Employees Over Time
100
As of Feb 2024
Notal Vision Address
7717 Coppermine Drive
Manassas,
20109-2506
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts